Continuous TAP blocks for major gynaecological surgery
Not Applicable
Completed
- Conditions
- Pain after major gynaecological oncology surgeryCancer
- Registration Number
- ISRCTN60295543
- Lead Sponsor
- Joint Research Governance Office, Imperial College Healthcare Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 19
Inclusion Criteria
Patients aged 30-75 undergoing elective gynaecological oncology surgery
Exclusion Criteria
1. Patients unable to give informed consent (mainly language difficulty)
2. Patients with contraindications to drugs specified in the protocol or participation in another medical trial involving medications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Morphine use via a PCA pump. The amount used will be recorded daily but the primary outcome will be the amount used up to 0800hr on Day 3 (after which the lidocaine infusion will be stopped)
- Secondary Outcome Measures
Name Time Method <br> 1. Pain score: Patients will be asked for their pain score (none, mild, moderate or severe) every morning at rest, on taking a deep breath, and on coughing<br> 2. Morphine side effects: Episodes of nausea and vomiting over the last 24 hours will be recorded daily. The day of the first post-operative bowel action will be noted<br> 3. Respiratory function: Peak expiratory flow rate will be recorded pre-operatively and daily from post-operative day 1<br> 4. Operative and clinical outcomes data, including the extent of the abdominal incisions and the duration of hospital stay<br> 5. Adverse events will also be recorded<br><br>